KraneShares Electric Vehicles and Future Mobility vs UnitedHealth Group Inc — how do they compare? KraneShares Electric Vehicles and Future Mobility trades at $29.85, while UnitedHealth Group Inc trades at $436 (market cap $382.83B). The key difference: UnitedHealth Group Inc pays a 2.2% dividend while KraneShares Electric Vehicles and Future Mobility pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| KARS | UNH | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $38.01 | $431.68 |
52-Week Low | $23.61 | $237.77 |
Market Cap | — | $382.83B |
Enterprise Value | — | $429.52B |
Dividend Yield | — | 2.2% |
Signals from Pluang's Aura AI — not financial advice
KARS trades at $29.15, down 0.98% with bearish technical signals across moving averages and oscillators. The stock shows oversold conditions with RSI at 27.23, while facing resistance at $30. Recent industry news highlights strong global EV sales growth and China's expanding market presence, though US adoption lags behind international markets.
The EV sector faces competitive pressures from Chinese manufacturers and regulatory uncertainty, while benefiting from rising fuel prices driving consumer demand. KARS's performance depends on broader industry trends rather than company-specific fundamentals, with technical indicators suggesting continued near-term pressure.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →